Ketamine plus Alcohol: What We Know and What We Can Expect about This

被引:6
|
作者
Correa Kobayashi, Natalia Harumi [1 ]
Farias, Sarah Viana [1 ]
Luz, Diandra Araujo [1 ]
Machado-Ferraro, Kissila Marvia [1 ]
da Conceicao, Brenda Costa [1 ]
Menezes da Silveira, Cinthia Cristina [1 ]
Pereira Fernandes, Luanna Melo [1 ]
Cartagenes, Sabrina de Carvalho [1 ]
Moraes Ferreira, Vania Maria [2 ]
Fontes-Junior, Eneas Andrade [1 ]
Ferraz Maia, Cristiane do Socorro [1 ]
机构
[1] Fed Univ Para, Fac Pharm, Inst Hlth Sci, Lab Pharmacol Inflammat & Behav, BR-66075110 Belem, Para, Brazil
[2] Univ Brasilia, Psychol Inst, Lab Psychobiol, Campus Univ Darcy Ribeiro Asa Norte, BR-70910900 Brasilia, DF, Brazil
关键词
ketamine; alcohol; drug abuse; addiction; toxicological effects; central nervous system; cardiorespiratory system; digestive system; renal system; CHRONIC ETHANOL EXPOSURE; NMDA RECEPTOR; URINARY-TRACT; NITRIC-OXIDE; K-HOLE; NEUROCOGNITIVE FUNCTION; PSYCHOTIC SYMPTOMS; RECREATIONAL USERS; DEPENDENT BLOCK; DRUG;
D O I
10.3390/ijms23147800
中图分类号
Q5 [生物化学]; Q7 [分子生物学];
学科分类号
071010 ; 081704 ;
摘要
Drug abuse has become a public health concern. The misuse of ketamine, a psychedelic substance, has increased worldwide. In addition, the co-abuse with alcohol is frequently identified among misusers. Considering that ketamine and alcohol share several pharmacological targets, we hypothesize that the consumption of both psychoactive substances may synergically intensify the toxicological consequences, both under the effect of drugs available in body systems and during withdrawal. The aim of this review is to examine the toxicological mechanisms related to ketamine plus ethanol co-abuse, as well the consequences on cardiorespiratory, digestive, urinary, and central nervous systems. Furthermore, we provide a comprehensive discussion about the probable sites of shared molecular mechanisms that may elicit additional hazardous effects. Finally, we highlight the gaps of knowledge in this area, which deserves further research.
引用
收藏
页数:45
相关论文
共 50 条
  • [21] Arterial Stiffness-What Do We Know about It and What Do We Expect from This Biomarker?
    Reiner, Zeljko
    JOURNAL OF CLINICAL MEDICINE, 2022, 11 (16)
  • [22] Mirrors Neuron System in Patients with Schizophrenia: What we Know and what we Can Expect in Near Future?
    Mitra, Sayantanava
    Kavoor, Anjana Rao
    Anwar, Zeeshan
    INDIAN JOURNAL OF PSYCHIATRY, 2016, 58 (05) : S33 - S34
  • [23] VCSELs in '98: What we have and what we can expect
    Coldren, LA
    Hegblom, ER
    Akulova, YA
    Ko, J
    Strzelecka, EM
    Hu, SY
    VERTICAL-CAVITY SURFACE-EMITTING LASERS II, 1998, 3286 : 2 - 16
  • [24] New pharmacologic agents for obstructive sleep apnoea: what do we know and what can we expect?
    Hedner, Jan
    Zou, Ding
    CURRENT OPINION IN PULMONARY MEDICINE, 2022, 28 (06) : 522 - 528
  • [25] Public Reporting of Cardiac Surgery Outcomes-What Do We Know, What Can We Expect?
    Shahian, David M.
    JOURNAL OF CARDIAC SURGERY, 2010, 25 (06) : 710 - 712
  • [26] HOW DO WE KNOW WHAT WE KNOW AND HOW CAN WE EXTEND WHAT WE KNOW
    ROSENBLOOM, DH
    PUBLIC ADMINISTRATION REVIEW, 1991, 51 (02) : 95 - 96
  • [27] What we know so far and what we can expect next: A molecular investigation of plant parasitism
    Ishida, Juliane Karine
    Costa, Elaine Cotrim
    GENETICS AND MOLECULAR BIOLOGY, 2024, 47
  • [28] WHAT WE KNOW AND WHAT WE NEED TO KNOW ABOUT PHYSICAL ACTIVITY AND ALCOHOL CONSUMPTION: IMPLICATIONS FOR ALCOHOL TREATMENT AND PREVENTION
    Magnan, Renee E.
    Stevens, Courtney
    Bryan, Angela D.
    ANNALS OF BEHAVIORAL MEDICINE, 2012, 43 : S163 - S163
  • [29] LAETRILE - WHAT WE KNOW AND WHAT WE DO ABOUT IT
    JONES, GT
    ABRAMSON, N
    JOURNAL OF THE FLORIDA MEDICAL ASSOCIATION, 1979, 66 (05): : 548 - 552
  • [30] WHAT CAN WE EXPECT OF PROBATIONERS?
    Nield, James W.
    SCHOOL AND SOCIETY, 1932, 36 (931): : 574 - 576